158 related articles for article (PubMed ID: 33042960)
1. Drug-Loaded Lipid-Coated Hybrid Organic-Inorganic "Stealth" Nanoparticles for Cancer Therapy.
Li X; Salzano G; Qiu J; Menard M; Berg K; Theodossiou T; Ladavière C; Gref R
Front Bioeng Biotechnol; 2020; 8():1027. PubMed ID: 33042960
[TBL] [Abstract][Full Text] [Related]
2. Porous nanoparticles with engineered shells release their drug cargo in cancer cells.
Qiu J; Li X; Rezaei M; Patriarche G; Casas-Solvas JM; Moreira-Alvarez B; Costa Fernandez JM; Encinar JR; Savina F; Picton L; Vargas-Berenguel A; Gref R
Int J Pharm; 2021 Dec; 610():121230. PubMed ID: 34718091
[TBL] [Abstract][Full Text] [Related]
3. Highly Porous Hybrid Metal-Organic Nanoparticles Loaded with Gemcitabine Monophosphate: a Multimodal Approach to Improve Chemo- and Radiotherapy.
Li X; Porcel E; Menendez-Miranda M; Qiu J; Yang X; Serre C; Pastor A; Desmaële D; Lacombe S; Gref R
ChemMedChem; 2020 Feb; 15(3):274-283. PubMed ID: 31765517
[TBL] [Abstract][Full Text] [Related]
4. Comb-like dextran copolymers: A versatile strategy to coat highly porous MOF nanoparticles with a PEG shell.
Cutrone G; Qiu J; Menendez-Miranda M; Casas-Solvas JM; Aykaç A; Li X; Foulkes D; Moreira-Alvarez B; Encinar JR; Ladavière C; Desmaële D; Vargas-Berenguel A; Gref R
Carbohydr Polym; 2019 Nov; 223():115085. PubMed ID: 31426973
[TBL] [Abstract][Full Text] [Related]
5. Efficient "green" encapsulation of a highly hydrophilic anticancer drug in metal-organic framework nanoparticles.
Rodriguez-Ruiz V; Maksimenko A; Anand R; Monti S; Agostoni V; Couvreur P; Lampropoulou M; Yannakopoulou K; Gref R
J Drug Target; 2015; 23(7-8):759-67. PubMed ID: 26453171
[TBL] [Abstract][Full Text] [Related]
6. Design of Engineered Cyclodextrin Derivatives for Spontaneous Coating of Highly Porous Metal-Organic Framework Nanoparticles in Aqueous Media.
Cutrone G; Li X; Casas-Solvas JM; Menendez-Miranda M; Qiu J; Benkovics G; Constantin D; Malanga M; Moreira-Alvarez B; Costa-Fernandez JM; García-Fuentes L; Gref R; Vargas-Berenguel A
Nanomaterials (Basel); 2019 Aug; 9(8):. PubMed ID: 31374940
[TBL] [Abstract][Full Text] [Related]
7. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
[TBL] [Abstract][Full Text] [Related]
8. A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.
Agostoni V; Horcajada P; Noiray M; Malanga M; Aykaç A; Jicsinszky L; Vargas-Berenguel A; Semiramoth N; Daoud-Mahammed S; Nicolas V; Martineau C; Taulelle F; Vigneron J; Etcheberry A; Serre C; Gref R
Sci Rep; 2015 Jan; 5():7925. PubMed ID: 25603994
[TBL] [Abstract][Full Text] [Related]
9. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled multifunctional core-shell highly porous metal-organic framework nanoparticles.
Qiu J; Li X; Steenkeste K; Barroca-Aubry N; Aymes-Chodur C; Roger P; Casas-Solvas JM; Vargas-Berenguel A; Rihouey C; Picton L; Gref R
Int J Pharm; 2020 May; 581():119281. PubMed ID: 32276089
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
[TBL] [Abstract][Full Text] [Related]
12. Solid-state NMR spectroscopy as a powerful tool to investigate the location of fluorinated lipids in highly porous hybrid organic-inorganic nanoparticles.
Porcino M; Li X; Gref R; Martineau-Corcos C
Magn Reson Chem; 2021 Sep; 59(9-10):1038-1047. PubMed ID: 33709480
[TBL] [Abstract][Full Text] [Related]
13. A non-covalent "click chemistry" strategy to efficiently coat highly porous MOF nanoparticles with a stable polymeric shell.
Aykaç A; Noiray M; Malanga M; Agostoni V; Casas-Solvas JM; Fenyvesi É; Gref R; Vargas-Berenguel A
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1606-1616. PubMed ID: 28137620
[TBL] [Abstract][Full Text] [Related]
14. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
Li J; Zhang Z; Li J; Cun JE; Pan Q; Gao W; Luo K; He B; Gu Z; Pu Y
Acta Biomater; 2022 Oct; 152():495-506. PubMed ID: 36087871
[TBL] [Abstract][Full Text] [Related]
15. GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness.
Giménez-Marqués M; Bellido E; Berthelot T; Simón-Yarza T; Hidalgo T; Simón-Vázquez R; González-Fernández Á; Avila J; Asensio MC; Gref R; Couvreur P; Serre C; Horcajada P
Small; 2018 Oct; 14(40):e1801900. PubMed ID: 30091524
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Investigation into the Selective Anticancer Cytotoxicity and Immune System Response of Surface-Functionalized, Dichloroacetate-Loaded, UiO-66 Nanoparticles.
Abánades Lázaro I; Haddad S; Rodrigo-Muñoz JM; Orellana-Tavra C; Del Pozo V; Fairen-Jimenez D; Forgan RS
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5255-5268. PubMed ID: 29356507
[TBL] [Abstract][Full Text] [Related]
18. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
20. Ti-Based nanoMOF as an Efficient Oral Therapeutic Agent.
Rojas S; Guillou N; Horcajada P
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22188-22193. PubMed ID: 31140777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
